{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:21:40Z","timestamp":1794712900924,"version":"4.9.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C42639\/A26988"],"award-info":[{"award-number":["C42639\/A26988"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5255\/A20936"],"award-info":[{"award-number":["C5255\/A20936"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_19049"],"award-info":[{"award-number":["MC_PC_19049"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_19049"],"award-info":[{"award-number":["MC_PC_19049"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["222800\/Z\/21\/Z"],"award-info":[{"award-number":["222800\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Emergence Canceropole Ile de France, Association pour la Recherche contre le cancer, Siric-Socrate, INCA-PLBIO"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Understanding the genetic and nongenetic determinants of tumor protein 53 (\n                    <jats:italic>TP53<\/jats:italic>\n                    )\n                    <jats:italic>-<\/jats:italic>\n                    mutation-driven clonal evolution and subsequent transformation is a crucial step toward the design of rational therapeutic strategies. Here we carry out allelic resolution single-cell multi-omic analysis of hematopoietic stem\/progenitor cells (HSPCs) from patients with a myeloproliferative neoplasm who transform to\n                    <jats:italic>TP53-<\/jats:italic>\n                    mutant secondary acute myeloid leukemia (sAML). All patients showed dominant\n                    <jats:italic>TP53<\/jats:italic>\n                    \u2018multihit\u2019 HSPC clones at transformation, with a leukemia stem cell transcriptional signature strongly predictive of adverse outcomes in independent cohorts, across both\n                    <jats:italic>TP53-<\/jats:italic>\n                    mutant and wild-type (WT) AML. Through analysis of serial samples, antecedent\n                    <jats:italic>TP53<\/jats:italic>\n                    -heterozygous clones and in vivo perturbations, we demonstrate a hitherto unrecognized effect of chronic inflammation, which suppressed\n                    <jats:italic>TP53<\/jats:italic>\n                    WT HSPCs while enhancing the fitness advantage of\n                    <jats:italic>TP53-<\/jats:italic>\n                    mutant cells and promoted genetic evolution. Our findings will facilitate the development of risk-stratification, early detection and treatment strategies for\n                    <jats:italic>TP53<\/jats:italic>\n                    -mutant leukemia, and are of broad relevance to other cancer types.\n                  <\/jats:p>","DOI":"10.1038\/s41588-023-01480-1","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T12:02:37Z","timestamp":1693828957000},"page":"1531-1541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":165,"title":["Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution"],"prefix":"10.1038","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-6968","authenticated-orcid":false,"given":"Alba","family":"Rodriguez-Meira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggiero","family":"Norfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe L.","family":"Ch\u00e9deville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haseeb","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0543-7397","authenticated-orcid":false,"given":"Eleni","family":"Louka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren W.","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Brierley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Edouard","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Demeule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6847-1525","authenticated-orcid":false,"given":"Matthew","family":"Bashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9100-2954","authenticated-orcid":false,"given":"Nikolaos","family":"Sousos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Moralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Subha Meem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Carrelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4074-1623","authenticated-orcid":false,"given":"Helene","family":"Guermouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Marzac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3151-1068","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Girodon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4705-202X","authenticated-orcid":false,"given":"William","family":"Vainchenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6477-4254","authenticated-orcid":false,"given":"J. Ross","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Plo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1362-3659","authenticated-orcid":false,"given":"Sten Eirik W.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8198-9663","authenticated-orcid":false,"given":"Bethan","family":"Psaila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supat","family":"Thongjuea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1911-146X","authenticated-orcid":false,"given":"Il\u00e9ana","family":"Antony-Debr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8522-1002","authenticated-orcid":false,"given":"Adam J.","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"1480_CR1","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.1158\/1078-0432.CCR-20-2272","volume":"26","author":"H Sill","year":"2020","unstructured":"Sill, H., Zebisch, A. & Haase, D. Acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations\u2014a distinct stem cell disorder. Clin. Cancer Res. 26, 5304\u20135309 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1480_CR2","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","volume":"26","author":"E Bernard","year":"2020","unstructured":"Bernard, E. et al. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. Nat. Med. 26, 1549\u20131556 (2020).","journal-title":"Nat. Med."},{"key":"1480_CR3","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","volume":"170","author":"ER Kastenhuber","year":"2017","unstructured":"Kastenhuber, E. R. & Lowe, S. W. Putting p53 in context. Cell 170, 1062\u20131078 (2017).","journal-title":"Cell"},{"key":"1480_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1182\/blood-2014-11-610543","volume":"125","author":"RC Lindsley","year":"2015","unstructured":"Lindsley, R. C. et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood 125, 1367\u20131376 (2015).","journal-title":"Blood"},{"key":"1480_CR5","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1200\/JCO.2014.60.0890","volume":"33","author":"LS Granfeldt \u00d8stg\u00e5rd","year":"2015","unstructured":"Granfeldt \u00d8stg\u00e5rd, L. S. et al. Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a national population-based cohort study. J. Clin. Oncol. 33, 3641\u20133649 (2015).","journal-title":"J. Clin. Oncol."},{"key":"1480_CR6","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1182\/blood-2016-10-696005","volume":"129","author":"AJ Mead","year":"2017","unstructured":"Mead, A. J. & Mullally, A. Myeloproliferative neoplasm stem cells. Blood 129, 1607\u20131616 (2017).","journal-title":"Blood"},{"key":"1480_CR7","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1158\/2159-8290.CD-20-1652","volume":"11","author":"H Celik","year":"2021","unstructured":"Celik, H. et al. A humanized animal model predicts clonal evolution and therapeutic vulnerabilities in myeloproliferative neoplasms. Cancer Discov. 11, 3126\u20133141 (2021).","journal-title":"Cancer Discov."},{"key":"1480_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood.2019000943","volume":"136","author":"AJ Dunbar","year":"2020","unstructured":"Dunbar, A. J., Rampal, R. K. & Levine, R. Leukemia secondary to myeloproliferative neoplasms. Blood 136, 61\u201370 (2020).","journal-title":"Blood"},{"key":"1480_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1182\/bloodadvances.2018015875","volume":"2","author":"TL Lasho","year":"2018","unstructured":"Lasho, T. L. et al. Targeted next-generation sequencing in blast phase myeloproliferative neoplasms. Blood Adv. 2, 370\u2013380 (2018).","journal-title":"Blood Adv."},{"key":"1480_CR10","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1182\/bloodadvances.2020002271","volume":"4","author":"D Luque Paz","year":"2020","unstructured":"Luque Paz, D. et al. Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation. Blood Adv. 4, 4887\u20134897 (2020).","journal-title":"Blood Adv."},{"key":"1480_CR11","doi-asserted-by":"publisher","first-page":"E5401","DOI":"10.1073\/pnas.1407792111","volume":"111","author":"R Rampal","year":"2014","unstructured":"Rampal, R. et al. Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms. Proc. Natl Acad. Sci. USA 111, E5401\u2013E5410 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1480_CR12","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1182\/bloodadvances.2018024018","volume":"2","author":"BK Marcellino","year":"2018","unstructured":"Marcellino, B. K. et al. Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53. Blood Adv. 2, 3581\u20133589 (2018).","journal-title":"Blood Adv."},{"key":"1480_CR13","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.3324\/haematol.2016.152363","volume":"102","author":"F Courtier","year":"2017","unstructured":"Courtier, F. et al. Genomic analysis of myeloproliferative neoplasms in chronic and acute phases. Haematologica 102, e11\u2013e14 (2017).","journal-title":"Haematologica"},{"key":"1480_CR14","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1038\/onc.2016.478","volume":"36","author":"T Tsuruta-Kishino","year":"2017","unstructured":"Tsuruta-Kishino, T. et al. Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera. Oncogene 36, 3300\u20133311 (2017).","journal-title":"Oncogene"},{"key":"1480_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/leu.2017.230","volume":"32","author":"B Kubesova","year":"2018","unstructured":"Kubesova, B. et al. Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status. Leukemia 32, 450\u2013461 (2018).","journal-title":"Leukemia"},{"key":"1480_CR16","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.molcel.2019.01.009","volume":"73","author":"A Rodriguez-Meira","year":"2019","unstructured":"Rodriguez-Meira, A. et al. Unravelling intratumoral heterogeneity through high-sensitivity single-cell mutational analysis and parallel RNA sequencing. Mol. Cell 73, 1292\u20131305 (2019).","journal-title":"Mol. Cell"},{"key":"1480_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nm.4336","volume":"23","author":"A Giustacchini","year":"2017","unstructured":"Giustacchini, A. et al. Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia. Nat. Med. 23, 692\u2013702 (2017).","journal-title":"Nat. Med."},{"key":"1480_CR18","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1182\/blood-2005-12-013748","volume":"108","author":"PJ Campbell","year":"2006","unstructured":"Campbell, P. J. et al. Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation. Blood 108, 3548\u20133555 (2006).","journal-title":"Blood"},{"key":"1480_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","volume":"19","author":"N Goardon","year":"2011","unstructured":"Goardon, N. et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 19, 138\u2013152 (2011).","journal-title":"Cancer Cell"},{"key":"1480_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ccell.2018.01.006","volume":"33","author":"CAG Booth","year":"2018","unstructured":"Booth, C. A. G. et al. Ezh2 and Runx1 mutations collaborate to initiate lympho-myeloid leukemia in early thymic progenitors. Cancer Cell 33, 274\u2013291 (2018).","journal-title":"Cancer Cell"},{"key":"1480_CR21","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/s41591-018-0269-2","volume":"24","author":"G Ledergor","year":"2018","unstructured":"Ledergor, G. et al. Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma. Nat. Med. 24, 1867\u20131876 (2018).","journal-title":"Nat. Med."},{"key":"1480_CR22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1182\/blood-2004-07-2864","volume":"105","author":"RA Mesa","year":"2005","unstructured":"Mesa, R. A. et al. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood 105, 973\u2013977 (2005).","journal-title":"Blood"},{"key":"1480_CR23","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/cncr.21297","volume":"104","author":"F Passamonti","year":"2005","unstructured":"Passamonti, F. et al. Leukemic transformation of polycythemia vera: a single center study of 23 patients. Cancer 104, 1032\u20131036 (2005).","journal-title":"Cancer"},{"key":"1480_CR24","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","volume":"37","author":"JM Granja","year":"2019","unstructured":"Granja, J. M. et al. Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia. Nat. Biotechnol. 37, 1458\u20131465 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1480_CR25","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P Van Galen","year":"2019","unstructured":"Van Galen, P. et al. Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell 176, 1265\u20131281 (2019).","journal-title":"Cell"},{"key":"1480_CR26","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner, J. W. et al. Functional genomic landscape of acute myeloid leukaemia. Nature 562, 526\u2013531 (2018).","journal-title":"Nature"},{"key":"1480_CR27","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"TJ Ley","year":"2013","unstructured":"Ley, T. J. et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059\u20132074 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1480_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aax3649","volume":"365","author":"S Boettcher","year":"2019","unstructured":"Boettcher, S. et al. A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science 365, 599\u2013604 (2019).","journal-title":"Science"},{"key":"1480_CR29","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1073\/pnas.0508143103","volume":"103","author":"K Wagner","year":"2006","unstructured":"Wagner, K. et al. Absence of the transcription factor CCAAT enhancer binding protein \u03b1 results in loss of myeloid identity in bcr\/abl-induced malignancy. Proc. Natl Acad. Sci. USA 103, 6338\u20136343 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1480_CR30","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ccr.2009.09.036","volume":"16","author":"O Bereshchenko","year":"2009","unstructured":"Bereshchenko, O. et al. Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C\/EBP\u03b1 mutant AML. Cancer Cell 16, 390\u2013400 (2009).","journal-title":"Cancer Cell"},{"key":"1480_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SW Ng","year":"2016","unstructured":"Ng, S. W. et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature 540, 433\u2013437 (2016).","journal-title":"Nature"},{"key":"1480_CR32","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1084\/jem.194.7.941","volume":"194","author":"D Bryder","year":"2001","unstructured":"Bryder, D. et al. Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation. J. Exp. Med. 194, 941\u2013952 (2001).","journal-title":"J. Exp. Med."},{"key":"1480_CR33","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1182\/blood.V86.8.2957.2957","volume":"86","author":"FW Jacobsen","year":"1995","unstructured":"Jacobsen, F. W., Stokke, T. & Jacobsen, S. E. Transforming growth factor-beta potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 86, 2957\u20132966 (1995).","journal-title":"Blood"},{"key":"1480_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2021.02.002","volume":"96","author":"Y Demerdash","year":"2021","unstructured":"Demerdash, Y., Kain, B., Essers, M. A. G. & King, K. Y. Yin and Yang: the dual effects of interferons on hematopoiesis. Exp. Hematol. 96, 1\u201312 (2021).","journal-title":"Exp. Hematol."},{"key":"1480_CR35","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1128\/JVI.00023-08","volume":"83","author":"S Trapp","year":"2009","unstructured":"Trapp, S. et al. Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. J. Virol. 83, 884\u2013895 (2009).","journal-title":"J. Virol."},{"key":"1480_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.htct.2017.12.003","volume":"40","author":"MDC Cacemiro","year":"2018","unstructured":"Cacemiro, M. D. C. et al. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation. Hematol. Transfus. Cell Ther. 40, 120\u2013131 (2018).","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"1480_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-9-1","volume":"9","author":"A Ngkelo","year":"2012","unstructured":"Ngkelo, A., Meja, K., Yeadon, M., Adcock, I. & Kirkham, P. A. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Gi\u03b1 dependent PI-3kinase signalling. J. Inflamm. 9, 1 (2012).","journal-title":"J. Inflamm."},{"key":"1480_CR38","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood-2010-10-315218","volume":"118","author":"SF Libregts","year":"2011","unstructured":"Libregts, S. F. et al. Chronic IFN-\u03b3 production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1\/PU.1 axis. Blood 118, 2578\u20132588 (2011).","journal-title":"Blood"},{"key":"1480_CR39","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature07815","volume":"458","author":"MA Essers","year":"2009","unstructured":"Essers, M. A. et al. IFN\u03b1 activates dormant haematopoietic stem cells in vivo. Nature 458, 904\u2013908 (2009).","journal-title":"Nature"},{"key":"1480_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1084\/jem.20131043","volume":"211","author":"EM Pietras","year":"2014","unstructured":"Pietras, E. M. et al. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J. Exp. Med. 211, 245\u2013262 (2014).","journal-title":"J. Exp. Med."},{"key":"1480_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature14131","volume":"520","author":"D Walter","year":"2015","unstructured":"Walter, D. et al. Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature 520, 549\u2013552 (2015).","journal-title":"Nature"},{"key":"1480_CR42","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1158\/2159-8290.CD-18-1391","volume":"9","author":"E Loizou","year":"2019","unstructured":"Loizou, E. et al. A gain-of-function p53-mutant oncogene promotes cell fate plasticity and myeloid leukemia through the pluripotency factor FOXH1. Cancer Discov. 9, 962\u2013979 (2019).","journal-title":"Cancer Discov."},{"key":"1480_CR43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.blre.2017.09.002","volume":"32","author":"P Boddu","year":"2018","unstructured":"Boddu, P. et al. Erythroleukemia-historical perspectives and recent advances in diagnosis and management. Blood Rev. 32, 96\u2013105 (2018).","journal-title":"Blood Rev."},{"key":"1480_CR44","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41588-019-0375-1","volume":"51","author":"I Iacobucci","year":"2019","unstructured":"Iacobucci, I. et al. Genomic subtyping and therapeutic targeting of acute erythroleukemia. Nat. Genet. 51, 694\u2013704 (2019).","journal-title":"Nat. Genet."},{"key":"1480_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1182\/blood-2008-10-180489","volume":"114","author":"CD Trainor","year":"2009","unstructured":"Trainor, C. D., Mas, C., Archambault, P., di Lello, P. & Omichinski, J. G. GATA-1 associates with and inhibits p53. Blood 114, 165\u2013173 (2009).","journal-title":"Blood"},{"key":"1480_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/461183a","volume":"461","author":"T Enver","year":"2009","unstructured":"Enver, T. & Jacobsen, S. E. Developmental biology: instructions writ in blood. Nature 461, 183\u2013184 (2009).","journal-title":"Nature"},{"key":"1480_CR47","doi-asserted-by":"publisher","first-page":"e20201541","DOI":"10.1084\/jem.20201541","volume":"218","author":"F Caiado","year":"2021","unstructured":"Caiado, F., Pietras, E. M. & Manz, M. G. Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. J. Exp. Med. 218, e20201541 (2021).","journal-title":"J. Exp. Med."},{"key":"1480_CR48","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.stem.2021.03.002","volume":"28","author":"D Hormaechea-Agulla","year":"2021","unstructured":"Hormaechea-Agulla, D. et al. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFN\u03b3 signaling. Cell Stem Cell 28, 1428\u20131442 (2021).","journal-title":"Cell Stem Cell"},{"key":"1480_CR49","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.aba9304","volume":"374","author":"S Avagyan","year":"2021","unstructured":"Avagyan, S. et al. Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis. Science 374, 768\u2013772 (2021).","journal-title":"Science"},{"key":"1480_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jaut.2017.06.010","volume":"85","author":"F Lussana","year":"2017","unstructured":"Lussana, F. & Rambaldi, A. Inflammation and myeloproliferative neoplasms. J. Autoimmun. 85, 58\u201363 (2017).","journal-title":"J. Autoimmun."},{"key":"1480_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ccell.2017.11.009","volume":"33","author":"M Kleppe","year":"2018","unstructured":"Kleppe, M. et al. Dual targeting of oncogenic activation and inflammatory signaling increases therapeutic efficacy in myeloproliferative neoplasms. Cancer Cell 33, 29\u201343 (2018).","journal-title":"Cancer Cell"},{"key":"1480_CR52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"The ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","unstructured":"The ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium Pan-cancer analysis of whole genomes. Nature 578, 82\u201393 (2020).","journal-title":"Nature"},{"key":"1480_CR53","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1182\/blood.V124.21.2373.2373","volume":"124","author":"A Hamblin","year":"2014","unstructured":"Hamblin, A. et al. Development and evaluation of the clinical utility of a next generation sequencing (NGS) tool for myeloid disorders. Blood 124, 2373 (2014).","journal-title":"Blood"},{"key":"1480_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/ng.3466","volume":"48","author":"X Zhou","year":"2016","unstructured":"Zhou, X. et al. Exploring genomic alteration in pediatric cancer using ProteinPaint. Nat. Genet. 48, 4\u20136 (2016).","journal-title":"Nat. Genet."},{"key":"1480_CR55","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil, E. et al. Genomic classification and prognosis in acute myeloid leukemia. N. Engl. J. Med. 374, 2209\u20132221 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1480_CR56","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","volume":"21","author":"CC Coombs","year":"2017","unstructured":"Coombs, C. C. et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 21, 374\u2013382 (2017).","journal-title":"Cell Stem Cell"},{"key":"1480_CR57","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","volume":"24","author":"P Desai","year":"2018","unstructured":"Desai, P. et al. Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat. Med. 24, 1015\u20131023 (2018).","journal-title":"Nat. Med."},{"key":"1480_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12484","volume":"7","author":"AL Young","year":"2016","unstructured":"Young, A. L., Challen, G. A., Birmann, B. M. & Druley, T. E. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat. Commun. 7, 12484 (2016).","journal-title":"Nat. Commun."},{"key":"1480_CR59","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41586-018-0321-x","volume":"559","author":"PR Loh","year":"2018","unstructured":"Loh, P. R. et al. Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations. Nature 559, 350\u2013355 (2018).","journal-title":"Nature"},{"key":"1480_CR60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-020-2430-6","volume":"584","author":"PR Loh","year":"2020","unstructured":"Loh, P. R., Genovese, G. & McCarroll, S. A. Monogenic and polygenic inheritance become instruments for clonal selection. Nature 584, 136\u2013141 (2020).","journal-title":"Nature"},{"key":"1480_CR61","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biostatistics\/kxh008","volume":"5","author":"AB Olshen","year":"2004","unstructured":"Olshen, A. B., Venkatraman, E. S., Lucito, R. & Wigler, M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5, 557\u2013572 (2004).","journal-title":"Biostatistics"},{"key":"1480_CR62","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/bioinformatics\/btl646","volume":"23","author":"ES Venkatraman","year":"2007","unstructured":"Venkatraman, E. S. & Olshen, A. B. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 23, 657\u2013663 (2007).","journal-title":"Bioinformatics"},{"key":"1480_CR63","doi-asserted-by":"publisher","first-page":"e1003118","DOI":"10.1371\/journal.pcbi.1003118","volume":"9","author":"M Lawrence","year":"2013","unstructured":"Lawrence, M. et al. Software for computing and annotating genomic ranges. PLoS Comput. Biol. 9, e1003118 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"1480_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56972-0","volume":"10","author":"M Bashton","year":"2020","unstructured":"Bashton, M. et al. Concordance of copy number abnormality detection using SNP arrays and Multiplex Ligation-dependent Probe Amplification (MLPA) in acute lymphoblastic leukaemia. Sci. Rep. 10, 45 (2020).","journal-title":"Sci. Rep."},{"key":"1480_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"1480_CR66","doi-asserted-by":"publisher","first-page":"100125","DOI":"10.1016\/j.xpro.2020.100125","volume":"1","author":"A Rodriguez-Meira","year":"2020","unstructured":"Rodriguez-Meira, A., O\u2019Sullivan, J., Rahman, H. & Mead, A. J. TARGET-Seq: a protocol for high-sensitivity single-cell mutational analysis and parallel RNA sequencing. STAR Protoc. 1, 100125 (2020).","journal-title":"STAR Protoc."},{"key":"1480_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1480_CR68","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"1480_CR69","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"1480_CR70","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1182\/blood.2019000519","volume":"134","author":"F Schischlik","year":"2019","unstructured":"Schischlik, F. et al. Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms. Blood 134, 199\u2013210 (2019).","journal-title":"Blood"},{"key":"1480_CR71","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"1480_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19119-8","volume":"11","author":"K Morita","year":"2020","unstructured":"Morita, K. et al. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat. Commun. 11, 5327 (2020).","journal-title":"Nat. Commun."},{"key":"1480_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0936-x","volume":"17","author":"K Jahn","year":"2016","unstructured":"Jahn, K., Kuipers, J. & Beerenwinkel, N. Tree inference for single-cell data. Genome Biol. 17, 86 (2016).","journal-title":"Genome Biol."},{"key":"1480_CR74","doi-asserted-by":"publisher","first-page":"109698","DOI":"10.1016\/j.celrep.2021.109698","volume":"36","author":"A Roy","year":"2021","unstructured":"Roy, A. et al. Transitions in lineage specification and gene regulatory networks in hematopoietic stem\/progenitor cells over human development. Cell Rep. 36, 109698 (2021).","journal-title":"Cell Rep."},{"key":"1480_CR75","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"},{"key":"1480_CR76","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"1480_CR77","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1038\/onc.2016.502","volume":"36","author":"M Fischer","year":"2017","unstructured":"Fischer, M. Census and evaluation of p53 target genes. Oncogene 36, 3943\u20133956 (2017).","journal-title":"Oncogene"},{"key":"1480_CR78","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.molcel.2020.04.008","volume":"78","author":"B Psaila","year":"2020","unstructured":"Psaila, B. et al. Single-cell analyses reveal megakaryocyte-biased hematopoiesis in myelofibrosis and identify mutant clone-specific targets. Mol. Cell 78, 477\u2013492 (2020).","journal-title":"Mol. Cell"},{"key":"1480_CR79","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno, G. et al. RNA velocity of single cells. Nature 560, 494\u2013498 (2018).","journal-title":"Nature"},{"key":"1480_CR80","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495\u2013502 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1480_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"1480_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02414-y","volume":"22","author":"M Barile","year":"2021","unstructured":"Barile, M. et al. Coordinated changes in gene expression kinetics underlie both mouse and human erythroid maturation. Genome Biol. 22, 197 (2021).","journal-title":"Genome Biol."},{"key":"1480_CR83","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","volume":"38","author":"V Bergen","year":"2020","unstructured":"Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408\u20131414 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1480_CR84","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41588-021-00791-5","volume":"53","author":"AP Heath","year":"2021","unstructured":"Heath, A. P. et al. The NCI genomic data commons. Nat. Genet. 53, 257\u2013262 (2021).","journal-title":"Nat. Genet."},{"key":"1480_CR85","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"1480_CR86","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1158\/1078-0432.CCR-20-0184","volume":"26","author":"G Anande","year":"2020","unstructured":"Anande, G. et al. RNA splicing alterations induce a cellular stress response associated with poor prognosis in acute myeloid leukemia. Clin. Cancer Res. 26, 3597\u20133607 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1480_CR87","doi-asserted-by":"publisher","first-page":"31980","DOI":"10.18632\/oncotarget.7881","volume":"7","author":"E Mahfoudhi","year":"2016","unstructured":"Mahfoudhi, E. et al. P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis. Oncotarget 7, 31980\u201331992 (2016).","journal-title":"Oncotarget"},{"key":"1480_CR88","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","volume":"119","author":"KP Olive","year":"2004","unstructured":"Olive, K. P. et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119, 847\u2013860 (2004).","journal-title":"Cell"},{"key":"1480_CR89","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/immu.200310005","volume":"33","author":"J De Boer","year":"2003","unstructured":"De Boer, J. et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33, 314\u2013325 (2003).","journal-title":"Eur. J. Immunol."},{"key":"1480_CR90","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1182\/blood-2004-08-3037","volume":"105","author":"JR G\u00f6thert","year":"2005","unstructured":"G\u00f6thert, J. R. et al. In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis. Blood 105, 2724\u20132732 (2005).","journal-title":"Blood"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-023-01480-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-023-01480-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-023-01480-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T19:06:32Z","timestamp":1694113592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-023-01480-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1480"],"URL":"https:\/\/doi.org\/10.1038\/s41588-023-01480-1","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.R.M. and A.J.M. are authors on a patent related to TARGET-seq (US Patent App. 17\/038,548). A patent relating to the TARGET-seq technique is licensed to Alethiomics, a spin-out company from the University of Oxford with equity owned by B.P. and A.J.M. and research funding to B.P. and A.J.M. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}